PETXOSOME NK
NK cell and immune cell activation
NK Cell Exosome Immune Cell Activation Solution
An immune cell activation solution based on NK cell (natural Killer Cell) exosomes.
NK cell-derived
High-purity exosomes extracted from human umbilical cord-derived NK cells
Serum-free patent
Application of serum-free patented technology blocking animal-derived serum
Pharmaceutical GMP facility manufacturing
Manufactured in pharmaceutical GMP facilities under strict quality control
Switch for dormant systemic immune network
Tumor cell apoptosis induction
Induces apoptosis of cancer cells and abnormal cells
Systemic immune cell reboot
Activates all immune cells including T cells, B cells, and macrophages.
Cytokine network normalization
Normalizes the activity of immune regulatory proteins such as IL and IFN.
Abnormal cell selection and control
Recognizes and controls tumor and virus-infected cells.
Management of severe intractable diseases caused by immune system collapse
Lymphoma, mammary tumors, mast cell tumors, hemangiosarcoma, osteosarcoma
FIP, FIV/FeLV
Severe allergies, IMT, immune-mediated skin diseases
IBD, age-related immune decline
Expert NK usage guide
Dosage
1 vial (10ml) per 1-10kg body weight
Frequency
Administration at 1-week intervals
Storage
Refrigeration required, freezing prohibited
Consult with your attending veterinarian for accurate dosage.